Rapid detection of subtype-selective nuclear hormone receptor binding with bacterial genetic selection

被引:10
作者
Skretas, G
Wood, DW
机构
[1] Princeton Univ, Dept Chem Engn, Princeton, NJ 08544 USA
[2] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA
基金
美国国家科学基金会;
关键词
D O I
10.1128/AEM.71.12.8995-8997.2005
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Subtype-selective nuclear hormone receptor modulators could potentially allow the development of valuable tissue-specific therapeutics. A simple biosensor that allows subtype-specific nuclear hormone receptor binding to be reflected by the growth phenotype of Escherichia coli cells has been constructed. This system will potentially enable the facile detection or evolution of subtype-selective hormone analogues.
引用
收藏
页码:8995 / 8997
页数:3
相关论文
共 19 条
[1]   PPARs: therapeutic targets for metabolic disease [J].
Berger, JP ;
Akiyama, TE ;
Meinke, PT .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (05) :244-251
[2]   Nuclear receptor ligand-binding domains three-dimensional structures, molecular interactions and pharmacological implications [J].
Bourguet, W ;
Germain, P ;
Gronemeyer, H .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (10) :381-388
[3]   Genetic definition of a protein-splicing domain: Functional mini-inteins support structure predictions and a model for intein evolution [J].
Derbyshire, V ;
Wood, DW ;
Wu, W ;
Dansereau, JT ;
Dalgaard, JZ ;
Belfort, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (21) :11466-11471
[4]   Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern [J].
Enmark, E ;
Pelto-Huikko, M ;
Grandien, K ;
Lagercrantz, S ;
Lagercrantz, J ;
Fried, G ;
Nordenskjöld, M ;
Gustafsson, JÅ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (12) :4258-4265
[5]   PPARs and the complex journey to obesity [J].
Evans, RM ;
Barish, GD ;
Wang, YX .
NATURE MEDICINE, 2004, 10 (04) :355-361
[6]   Principles for modulation of the nuclear receptor superfamily [J].
Gronemeyer, H ;
Gustafsson, JÅ ;
Laudet, V .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (11) :950-964
[7]   What pharmacologists can learn from recent advances in estrogen signalling [J].
Gustaftson, JÅ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (09) :479-485
[8]   Engineered cell lines as a tool for monitoring biological activity of hormone analogs [J].
Joyeux, A ;
Balaguer, P ;
Germain, P ;
Boussioux, AM ;
Pons, M ;
Nicolas, JC .
ANALYTICAL BIOCHEMISTRY, 1997, 249 (02) :119-130
[9]   A proteomic microarray approach for exploring ligand-initiated nuclear hormone receptor pharmacology, receptor selectivity, and heterodimer functionality [J].
Kim, SH ;
Tamrazi, A ;
Carlson, KE ;
Katzenellenbogen, JA .
MOLECULAR & CELLULAR PROTEOMICS, 2005, 4 (03) :267-277
[10]   Estrogen receptor microarrays: Subtype-selective ligand binding [J].
Kim, SH ;
Tamrazi, A ;
Carlson, KE ;
Daniels, JR ;
Lee, IY ;
Katzenellenbogen, JA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (15) :4754-4755